Precision therapies take aim at non-Hodgkin’s lymphoma
Elie Dolgin • November 14, 2018
The dramatic success of ibrutinib has created a more hopeful reality for people with lymphoma, as targeted therapies fill the pipeline.
Continue reading here.
The detailed scans could inspire robots and biomechanical designs.
But the rise of robots and AI may disrupt the sport’s ethos.